ESR1 and breast cancer: IL-6 has been implicated in numerous protumoral effects in breast cancer, including promotion of metastasis by hijacking ER transcriptional program (72), CSC maintenance and chemoresistance (73), and recruitment of myeloid-derived suppressor cells (MDSCs) (74).